Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

1,554 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,554 results

Not applicableLooking for participantsNCT05317494
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

Who this might be right for
Acute Myeloid Leukemia
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT00261703
What this trial is testing

Docetaxel in Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Sanofi 439
Testing effectiveness (Phase 2)WithdrawnNCT02413853
What this trial is testing

Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer

Who this might be right for
Colorectal AdenocarcinomaStage IVA Colorectal CancerStage IVB Colorectal Cancer
University of Southern California
Testing effectiveness (Phase 2)UnknownNCT05008237
What this trial is testing

Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study

Who this might be right for
Salivary Gland Cancer
Samsung Medical Center 42
Testing effectiveness (Phase 2)Study completedNCT01921673
What this trial is testing

Dovitinib Plus Docetaxel in Gastric Cancer

Who this might be right for
Gastric Cancer
Asan Medical Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT05460000
What this trial is testing

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
North Eastern German Society of Gynaecological Oncology 640
Testing effectiveness (Phase 2)Study completedNCT00444587
What this trial is testing

Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Study completedNCT01709487
What this trial is testing

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Jules Bordet Institute 19
Testing effectiveness (Phase 2)UnknownNCT04613804
What this trial is testing

Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy

Who this might be right for
NSCLC Stage IV
Fujian Cancer Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04956692
What this trial is testing

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

Who this might be right for
Non-Small Cell Lung Cancer
Merck Sharp & Dohme LLC 531
Not applicableStudy completedNCT00562458
What this trial is testing

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 200
Not applicableActive Not RecruitingNCT05415358
What this trial is testing

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Who this might be right for
Lung Cancer, Nonsmall Cell
Wake Forest University Health Sciences 23
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Early research (Phase 1)Looking for participantsNCT06610799
What this trial is testing

Study of IBI363 in Patients with Advanced First-line Gastric Cancer

Who this might be right for
IBI363 + Chemotherapy
Xiangdong Cheng 40
Testing effectiveness (Phase 2)Ended earlyNCT02846792
What this trial is testing

Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer

Who this might be right for
ALK Gene TranslocationEGFR Activating MutationRecurrent Non-Small Cell Lung Carcinoma+3 more
University of Washington 5
Testing effectiveness (Phase 2)UnknownNCT05621434
What this trial is testing

Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Recurrent/Metastatic Breast Cancer
Fujian Medical University 63
Testing effectiveness (Phase 2)UnknownNCT05023109
What this trial is testing

GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC

Who this might be right for
Biliary Tract Carcinoma
Shanghai Zhongshan Hospital 45
Not applicableLooking for participantsNCT06087783
What this trial is testing

PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy

Who this might be right for
Gynecologic Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 50
Large-scale testing (Phase 3)UnknownNCT03389659
What this trial is testing

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Who this might be right for
Vitamin D3
Tianjin Medical University Cancer Institute and Hospital 750
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07069270
What this trial is testing

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

Who this might be right for
VunakizumabAdebrelimabSmall Cell Lung Cancer
Fujian Cancer Hospital 28
Load More Results